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Abstract
Sexual dimorphism in body weight, fat distribution, and metabolic disease has been attributed largely to differential effects
of male and female gonadal hormones. Here, we report that the number of X chromosomes within cells also contributes to
these sex differences. We employed a unique mouse model, known as the ‘‘four core genotypes,’’ to distinguish between
effects of gonadal sex (testes or ovaries) and sex chromosomes (XX or XY). With this model, we produced gonadal male and
female mice carrying XX or XY sex chromosome complements. Mice were gonadectomized to remove the acute effects of
gonadal hormones and to uncover effects of sex chromosome complement on obesity. Mice with XX sex chromosomes
(relative to XY), regardless of their type of gonad, had up to 2-fold increased adiposity and greater food intake during
daylight hours, when mice are normally inactive. Mice with two X chromosomes also had accelerated weight gain on a high
fat diet and developed fatty liver and elevated lipid and insulin levels. Further genetic studies with mice carrying XO and
XXY chromosome complements revealed that the differences between XX and XY mice are attributable to dosage of the X
chromosome, rather than effects of the Y chromosome. A subset of genes that escape X chromosome inactivation exhibited
higher expression levels in adipose tissue and liver of XX compared to XY mice, and may contribute to the sex differences in
obesity. Overall, our study is the first to identify sex chromosome complement, a factor distinguishing all male and female
cells, as a cause of sex differences in obesity and metabolism.
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Introduction
Obesity represents a risk factor for many types of metabolic
disease, including diabetes, coronary heart disease, osteoarthritis,
and even cancer. The study of rare mutations in humans and
induced mutations in mouse models has identified numerous
genetic factors that influence energy balance [1,2,3]. Less is known,
however, about common genetic factors that may contribute to
moderate differences in body fat storage among individuals in a
population [4]. In humans and many other mammals, differences
exist between males and females in the amounts and anatomical
distribution of fat storage [5,6,7,8,9]. In general, males tend to have
more visceral fat while females have more lower body and
subcutaneous fat [10]. The two sexes also differ in the levels of
adipose tissue-derived hormones leptin and adiponectin [11,12,13],
and in the response of fat store depletion to caloric restriction [14].
These differences may contribute to differences between men and
women in susceptibility to metabolic disease.
The genetic origins of sex differences in fat tissue accumulation
are not well understood. Most studies have focused on the role of
gonadal hormones (reviewed in [15,16]. It is well established that
the reduction in levels of estrogens, progestins, and androgens
occurring at menopause in women increases central fat accumu-
lation and risk for diabetes, cardiovascular diseases and other
disorders [17]. Further evidence that estrogens play an important
role in fat metabolism comes from mouse studies. For example,
both male and female mice lacking estrogen receptor a have
increased white adipose tissue mass and insulin resistance [18]. In
men, the accumulation of excess abdominal adipose tissue is
associated with low levels of gonadal androgens [19]. Hyperan-
drogenism is also associated with increased abdominal obesity in
women with polycystic ovarian syndrome [20]. Androgen
receptor-deficient male mice develop late onset obesity, particu-
larly affecting visceral fat [21,22]. In addition, the administration
of dihydrotestosterone suppresses the development of subcutane-
ous adipose tissue in wild-type but not androgen receptor-deficient
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and females influence body fat, albeit in distinct ways.
Although gonadal hormones are a key determinant of sexual
dimorphism in body fat and metabolism, it is notable that even
prior to the differentiation of the gonads, human and mouse male
embryos are larger than female embryos, suggesting that non-
gonadal factors also contribute [23,24]. In addition to gonadal
hormones, an additional fundamental genetic difference exists
within every cell in the body of females compared to males
(reviewed in [25,26,27,28]. This is the presence in female cells of
two X chromosomes, and in male cells of an X and a Y
chromosome. The Y chromosome, and specifically the Sry gene
located there, initiates differentiation of the testes. Mice that have
a Y chromosome from which Sry has been deleted develop ovaries
rather than testes. Conversely, an Sry transgene inserted onto
autosome is sufficient to convert XX female mice to gonadal males
[29]. Inactivation of one X chromosome in each non-germline XX
cell greatly reduces the sex difference in level of expression of X
genes that is predicted based on the number of copies of X genes
[30]. However, a finite set of genes on both mouse and human X
chromosomes escape inactivation, and would therefore be
expected to exhibit higher expression levels in XX compared to
XY cells [31,32,33,34]. Recent studies indicate that genes escaping
X chromosome inactivation exhibit elevated expression in
metabolic tissues from XX compared to XO mice [35], and
could potentially contribute to sex differences in metabolic
phenotypes.
In the present study, we utilize the Four Core Genotypes (FCG)
mouse model to distinguish between the effects of gonadal sex
(testes or ovaries) and sex chromosomes (XX or XY) on adiposity
and related metabolic traits [25,26,27,36]. The FCG model allows
the generation of gonadal male and female mice carrying either
XX or XY sex chromosome complements. Specifically, the FCG
Y chromosome sustained a mutation deleting the Sry gene (yielding
the ‘‘Y minus’’ chromosome, Y
2), which is complemented in some
mice by an Sry transgene located on an autosome. Mice having
both the Y
2 chromosome and the Sry transgene will develop
normally as fertile gonadal male mice. If these mice are bred to a
normal female (XX), four types of progeny are produced: female
mice with ovaries and XY or XX sex chromosomes (XYF and
XXF, respectively), and male mice with testes and XY or XX sex
chromosomes (XYM and XXM, respectively). If differences in a
trait of interest occur between the gonadal male mice (XYM and
XXM) and gonadal female mice (XYF and XXF), it is most likely
related to differences in gonadal hormones, although the groups
also potentially differ because of possible effects of Sry on non-
gonadal tissues. By contrast, differences between XX and XY mice
suggest a sex chromosome effect, likely directly caused by the
difference in number of X or Y chromosomes.
In our study, FCG mice were gonadectomized as adults to
remove the acute sex differences resulting from gonadal hormones,
and thereby uncover the contribution of sex chromosome
complement. We found that gonadectomized XX mice of both
gonadal sexes have two-fold increased adiposity compared to XY
mice of either gonadal sex. Further genetic studies with mice
carrying XO and XXY chromosome complements revealed that
the difference is attributable to dosage of the X chromosome,
rather than effects of the Y chromosome. These results demon-
strate a fundamental difference in adiposity and metabolism
conferred by genes on the sex chromosomes, and specifically
implicate X chromosome genes as the direct cause of these
differences. These results further suggest that X chromosome
genes whose expression levels are influenced by dosage or parental
imprinting are candidates for metabolic disease differences in men
and women.
Results
Sex chromosome complement influences body weight
and fat mass independent of sex hormones
To determine whether sex chromosome effects contribute to sex
differences in body weight and fat mass in adulthood, we
examined these traits in C57BL/6 FCG mice (XX gonadal
females, XX gonadal males, XY gonadal females, and XY gonadal
males). Mice were maintained on a standard chow diet with low
fat content (5% by weight). At the time of weaning at postnatal day
21, the four groups of FCG mice did not differ in body weight
(Figure 1A). By 45 days of age, gonadal males of either sex
chromosome complement were approximately 20% heavier than
gonadal females. At 75 days of age the gonadal males were 25%
(XX background) or 28% (XY background) heavier than
corresponding gonadal females (Figure 1B, time 0). Importantly,
however, in these gonadally intact mice there was also a significant
influence of sex chromosomes on body weight. At 75 days of age,
XX mice were heavier than XY mice by 6.3% (XX.XY gonadal
males) and 8.8% (XX.XY gonadal females) (p,0.0001)
(Figure 1B, time 0).
Differences observed between male and female gonadally intact
FCG mice can be attributed to either activational effects of
gonadal hormones (reversible effects caused by sex differences in
on-going action of gonadal hormones) or organizational effects
(long-lasting or permanent gonadal hormone effects exerted at an
earlier stage of development). To distinguish between these
alternatives, mice were gonadectomized at 75 days of age to
remove activational effects of gonadal hormones. At the time of
gonadectomy, male XY and XX mice had significantly higher
body weight than female XX and XY mice, although XX mice of
either gonadal type weighed more than XY mice, as described
above (Figure 1B). In the 4 weeks following gonadectomy (GDX),
the body weights of all genotypes converged, and differences
between mice that were originally gonadal males and females
disappeared (Figure 1B). By 7 weeks, there emerged significant
Author Summary
Differences exist between men and women in the
development of obesity and related metabolic diseases
such as type 2 diabetes and cardiovascular disease.
Previous studies have focused on the sex-biasing role of
hormones produced by male and female gonads, but
these cannot account fully for the sex differences in
metabolism. We discovered that removal of the gonads
uncovers an important genetic determinant of sex
differences in obesity—the presence of XX or XY sex
chromosomes. We used a novel mouse model to tease
apart the effects of male and female gonads from the
effects of XX or XY chromosomes. Mice with XX sex
chromosomes (relative to XY), regardless of their type of
gonad, had increased body fat and ate more food during
the sleep period. Mice with two X chromosomes also had
accelerated weight gain, fatty liver, and hyperinsulinemia
on a high fat diet. The higher expression levels of a subset
of genes on the X chromosome that escape inactivation
may influence adiposity and metabolic disease. The effect
of X chromosome genes is present throughout life, but
may become particularly significant with increases in
longevity and extension of the period spent with reduced
gonadal hormone levels.
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PLoS Genetics | www.plosgenetics.org 2 May 2012 | Volume 8 | Issue 5 | e1002709Figure 1. Increased body weight and fat mass in XX versus XY mice on a chow diet. (A) Body weight of four core genotype (FCG) mice at
day 21 and day 45, prior to gonadectomy (GDX), and at 10 months after GDX. F, gonadal female; M, gonadal male. Values represent the mean 6 SEM
for the number of animals indicated in each bar. Significant comparisons for sex chromosome complement and for gonadal sex are denoted by
brackets. A significant interaction of sex chromosome complement and gonadal sex is denoted by ‘‘Int.’’. The p values are as described at the end of
the legend. (B) Body weight curve for FCG mice from the point of gonadectomy through 10 months following gonadectomy. Values represent mean
6 SEM. Values are significantly different between mice with XX vs. XY genotypes beginning at week 7 following GDX and beyond that. (C) Body
composition of mice in panel (B) determined by NMR in FCG mice at 10 months after GDX. (D) Fat pad mass in mice from panel (B) at 10 months
following GDX expressed as absolute mass (grams) or relative to kidney weight, which is invariant among the genotypes. (E) Plasma leptin levels and
leptin mRNA levels in inguinal adipose tissue. *, p,0.05; **, p,0.01; ***, p,0.001; {,p ,0.0001; {,p ,0.000001.
doi:10.1371/journal.pgen.1002709.g001
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weighing more than XY mice (p,0.000005; Figure 1). At 10
months after GDX, the XX mice weighed 24% more than XY
mice (p,0.0001, Figure 1A). In addition, XX gonadal females
continued to weigh more than XX gonadal males despite the
absence of gonadal secretions for 10 months (Figure 1A, p,0.01
for XX female vs. XX male mice), suggesting an interaction
between XX sex chromosome complement and long-acting
(organizational) gonadal hormone effects (interaction p,0.05).
Thus, the male-female difference in number of X chromosomes
influences body weight in the opposite direction to the male-
female difference in gonadal hormones.
The increased body weight in XX compared to XY mice
reflects a near doubling of the absolute fat mass as ascertained by
NMR analysis of whole mice, with 88% higher fat mass in XX
compared to XY mice (Figure 1C). When expressed as a percent of
body weight, XX mice had 50% higher proportional fat mass than
XY mice (p,0.00001, Figure 1C). This dramatic difference in fat
mass between XX and XY mice is particularly striking considering
that the mice were fed a standard mouse chow diet with very low
fat content. XX mice also had slightly higher lean body mass than
XY mice (Figure 1C). The increased total body adiposity of XX
compared to XY mice was reflected in isolated fat pad mass
(Figure 1D; p,0.0005 for absolute fat pad mass, p,0.005 for mass
relative to kidney; kidney weight did not differ among genotypes).
Fat mass, percent lean mass, and fat pad mass all exhibited
significant sex chromosome effects, and also significant interac-
tions between sex chromosome and gonadal sex (indicated in
Figure 1A, 1C and 1D by ‘Int’).
In parallel with the increased adiposity, plasma leptin levels
were elevated 2–3-fold in XX compared to XY mice (p,0.00005)
(Figure 1E). Plasma leptin was also higher in females (p,0.05), but
only in XX mice (interaction p,0.05). This suggests that long
lasting gonadal effects, as well as genetic factors conferred by sex
chromosome complement, directly or indirectly influenced leptin
levels. Leptin mRNA levels in adipose tissue mirrored plasma
leptin levels, with highest levels in XX mice (p,0.0005 vs. XY
mice), and significantly higher levels in mice that previously had
ovaries rather than testes (p,0.01) (Figure 1E).
XX mice exhibit increased daytime food intake preceding
increased body weight
To identify metabolic differences that could contribute to the
increased adiposity of XX mice, we measured food intake, physical
activity, and energy expenditure parameters while mice were
housed in metabolic cages. We performed these studies at two
ages: (1) at 4 weeks following gonadectomy, at which time the body
weights for all four genotypes were similar and measurements were
not complicated by differences in body weight or composition, and
(2) at 10 months after gonadectomy, after body weight differences
in XX vs. XY mice were pronounced (see Figure 1B).
At 4 weeks post-GDX, we detected a difference among the
genotypes in food intake patterns monitored continuously
throughout the circadian cycle. During the dark period when
mice typically consume 70% of total calories [37], gonadal female
mice of both XX and XY chromosome complements consumed
more than gonadal males (p,0.05; Figure 2A). Since these
measurements were made only 4 weeks after GDX, this may
reflect lingering effects of gonadal secretions. However, during the
daytime, food intake was significantly higher in XX females and
males compared to XY mice (p,0.01; Figure 2A and 2C). Since
this difference occurred at an age when no differences exist in
body weight, the increased daytime food intake is likely to
contribute to subsequent divergence of body weight between XX
and XY mice. At 10 months after GDX, the average absolute food
intake for all genotypes was reduced compared to values at 4 weeks
post-GDX, but no significant differences in food intake were
observed among the four genotypes (Figure 2B).
Using indirect calorimetry, we detected significant sex chromo-
some effects on respiratory quotient (RQ), a measure of the
relative reliance on carbohydrate (RQ=1) and fat substrates
(RQ=0.7) as metabolic fuel. At four weeks post-GDX, all mice
exhibited the expected diurnal variation in RQ, with highest
values in the dark phase. Notably, however, XX mice maintained
a significantly higher RQ than XY mice during the light phase
(Figure 2D), which may be related to the differential feeding
pattern in XX mice (Figure 2A). In addition, compared to XY
mice, XX mice exhibited a smaller amplitude change in RQ from
dark to light periods (D RQ), suggesting reduced flexibility in fuel
switching (Figure 2D). By contrast, at 10 months post-GDX, after
XX mice had accumulated nearly twice as much adipose tissue as
XY mice, the pattern of fuel utilization had changed. At this point,
the XX mice had lower RQ than XY mice during the dark phase
(Figure 2E), indicating increased fat utilization in the fed state,
possibly an adaptive change in response to the excess fat storage.
Besides food intake and RQ, other energy balance parameters
did not differ significantly among the four genotypes. These
include oxygen consumption (which was assessed per mouse, per
lean body mass [38], and via linear regression [39] to account for
contributions of both lean and fat mass in energy metabolism),
thermogenic gene expression, and physical activity in the
horizontal and vertical planes (Figure S1). Thus, the key
differences in energy metabolism between XX and XY mice were
increased daytime food intake and reduced flexibility in RQ in XX
mice. Both of these were apparent prior to the divergence in body
weight.
Despite the greater adiposity, XX mice did not exhibit
substantially impaired glucose homeostasis. At four weeks after
GDX, fasting glucose levels were higher in gonadal female than
gonadal male mice (p,0.0001), and slightly higher in XX than
XY mice (p,0.05); there were no differences in fasting insulin
levels among the genotypes (Figure S2A). At ten months after
GDX when XX mice had considerably greater adiposity, glucose
and insulin levels were similar among the four genotypes, and no
differences were revealed by glucose tolerance test (Figure S2A).
The ability to maintain glucose homeostasis despite excess fat
storage in the XX mice may be related to adaptive changes in
metabolism in these mice. For example, at ten months after GDX
when XX mice had substantially higher fat mass, they exhibited
increased expression of fatty acid oxidation genes encoding acyl
CoA oxidase (Aox1) and carnitine palmitoyl transferase (Cpt1)i n
both muscle and liver (Figure S2B). Increased fatty acid oxidation
may reduce the extent of lipid accumulation in liver and skeletal
muscle, and prevent impaired glucose homeostasis.
Enhanced weight gain, dyslipidemia, and fatty liver in XX
mice on a high fat diet
As described above, on a chow diet containing minimal fat, XX
mice accumulate excess adipose tissue without impaired glucose
homeostasis. Metabolic dysregulation in human obesity typically
occurs in the presence of a more stressful nutritional environment.
We hypothesized that a combination of sex chromosome
complement and a high fat diet may make XX mice more
vulnerable to metabolic dysregulation than XY mice. To test this,
we placed FCG on a high fat, simple carbohydrate diet that
promotes weight gain [40]. Mice were gonadectomized at 75 days
of age, continued on a chow diet for 4 weeks, and then fed the high
fat diet for 16 weeks. As shown in Figure 3A, the mice of all four
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diet. However, within just 3 days of beginning the high fat diet, the
XX and XY mice diverged, with significantly higher body weight
in XX gonadal males and females than in the corresponding XY
mice (p,0.005). XX mice continued to gain weight at an
accelerated pace throughout most of the 16 weeks, and weighed
about 15% more than XY mice at the end of the diet
(p,0.000005). The enhanced weight gain on the high fat diet
appeared to obscure the male-female difference in XX mice that
was observed on the chow diet (Figure 1B).
Figure 2. Altered food intake and RQ in XX versus XY mice. Mice were individually housed in metabolic cages to assess food take and energy
balance parameters continually throughout the diurnal cycle. (A, B) Food intake determined at 4 weeks or 10 months following GDX. Values represent
the mean 6 SEM food intake summed over two dark or two light periods. Data shown represent raw values; normalization to body weight or to lean
body mass gave the same outcome. (C) Food intake patterns throughout 3 nights and 2 days. At left, lines represent mean values for XX (n=8) and
XY (n=10) mice; at right, lines represent mean values for gonadal females (n=9) and gonadal males (n=9). (D, E) Mean Respiratory Quotient (RQ) 6
SEM for light and dark periods determined at 4 weeks or 10 months following GDX. At right, the change in RQ between dark and light periods (D RQ)
is shown. *, p,0.05; **, p,0.01; ***, p,0.001; {,p ,0.000001.
doi:10.1371/journal.pgen.1002709.g002
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PLoS Genetics | www.plosgenetics.org 5 May 2012 | Volume 8 | Issue 5 | e1002709Figure 3. Enhanced weight gain and fat mass in XX compared to XY mice fed a high fat-high carbohydrate diet. (A) FCG mice were fed
a high fat-high carbohydrate diet beginning at 4 weeks following GDX (week 0). XX mice first exhibited significantly higher body weight beginning at
3 days on the diet (arrow), and throughout the remainder of the study. (B) Body composition was determined by NMR at 16 weeks of the high fat-
high carbohydrate diet. Fat and lean mass are shown as absolute mass and as percent of total body weight (BW). (C) Plasma leptin levels were higher
in XX mice than XY mice at the end of the 16 week high fat diet period, and higher in gonadal females than gonadal males. (D) Tissue weights were
determined by excision after 16 weeks on the high fat-high carbohydrate diet. Kidney weight did not differ among the four genotypes. Inguinal and
gonadal fat pads are shown as absolute weights and normalized to kidney weight. Values shown for all bars represent mean 6 SEM for the number
of each genotype indicated. *, p,0.05; **, p,0.01; ***, p,0.001; {,p ,0.0001; {,p ,0.000001.
doi:10.1371/journal.pgen.1002709.g003
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weeks on the high fat diet, XX mice had higher absolute fat mass
than XY mice (p,0.005), but the increase in fat mass was not
significant when expressed as a proportion of body weight
(Figure 3B). Nevertheless, the increased fat mass was reflected in
elevated plasma leptin levels in XX compared to XY mice
(p,0.000001); leptin levels were also significantly higher in female
vs. male mice (p,0.01; interaction of sex by sex chromosome
complement p,0.05) (Figure 3C). Absolute lean mass was also
increased in XX mice (p,0.00005), but not when expressed as a
proportion of body weight (Figure 3B). Thus, it appears that the
greater increase in body weight observed in XX compared to XY
mice on a high fat diet is attributable to increases in both fat and
lean mass, and that XX mice exhibit increased absolute fat mass
and circulating leptin levels.
The analysis of tissue weights of mice after 16 weeks on the high
fat diet revealed sex chromosome effects on the liver and adipose
tissue depots. Absolute kidney weight did not differ among the four
genotypes despite differences in body weight (Figure 3D), and was
used to normalize the weights of other tissues. Inguinal subcuta-
neous fat pads weighed more in XX compared to XY mice
(Figure 3D; absolute weight, p,0.0005; normalized to kidney,
p,0.001). We also detected a sex chromosome by gonadal sex
interaction in inguinal fat pad weight when normalized to kidney
weight (p=0.006), suggesting a role for organizational hormone
action in combination with XX or XY status in determining
subcutaneous fat pad expansion on a high fat diet. Unexpectedly,
the gonadal fat depot showed the opposite pattern, with slightly
higher values in XY mice expressed both as absolute weight
(p,0.05) and normalized weight (p,0.05) (Figure 3D). These
results indicate that distinct genetic and hormonal factors may
influence the expansion of the gonadal and inguinal fat depots on a
high fat diet.
The high fat diet elicited formation of a fatty liver specifically in
XX mice. XX mice exhibited a significant increase in liver weight,
an abundance of lipid droplets, and increased triglyceride content
(p,0.0005, XX vs. XY mice) (Figure 4A, 4B). The XX mice also
exhibited evidence of reduced insulin sensitivity, as fasting insulin
levels and HOMA were elevated 2-fold compared to XY mice in
the presence of similar glucose levels (Figure 4C). These metabolic
disturbances were not associated with increased circulating
triglyceride or free fatty acid levels in XX mice, which instead
differed between gonadal males and females (Figure 4D). This
suggests that triglyceride and fatty acid levels are influenced by
organizational hormone effects rather than sex chromosome
complement, and are not likely an underlying factor in the
development of the fatty liver in XX vs. XY mice.
Gene expression in liver of mice fed the high fat diet showed
enhanced expression of lipogenic factors, including the transcrip-
tion factor peroxisome proliferator-activated receptor c, and the
triglyceride biosynthetic enzyme diacylglycerol acyltransferase 1
(Figure 4E). Hepatic expression of genes encoding proteins
involved in fatty acid uptake (Cd36), fatty acid synthesis (fatty
acid synthase), and fatty acid desaturation (stearoyl CoA desatur-
ase) were not significantly different among the four genotypes (data
not shown). Despite the increased triglyceride accumulation, fatty
acid oxidation gene expression was also elevated in XX compared
to XY liver (Figure 4F; p,0.005). This pattern was also observed
in XX mice fed the chow diet (Figure S2B), and may represent an
adaptive or compensatory response that prevents even more
pronounced fat storage in XX mice. In contrast to liver, Aox1 and
Cpt1b mRNA levels in muscle correlated with gonadal sex rather
than sex chromosome complement (Figure 4G). Metabolic gene
expression is clearly under complex control, with sex chromo-
somes and gonadal sex effects having differing roles in specific
tissues and conditions. Overall, our results reveal that the XX
chromosome complement led to accelerated weight gain and less
desirable metabolic profile than XY mice in response to a high fat
diet.
The number of X chromosomes, not the presence of the
Y chromosome, determines differences in body weight
and adiposity
XX mice differ genetically from XY mice in both the dose of the
X chromosome and in the absence of a Y chromosome. We
analyzed body weight and fat mass in mouse strains with abnormal
Y chromosomes that allow the dissection of effects of X and Y
chromosome number. As described below, our results indicate that
the XX vs. XY difference is caused by genes on the X
chromosome and not the Y chromosome.
We took advantage of mice carrying an unusual Y chromosome,
Y*, that undergoes abnormal recombination with the X chromo-
some, producing mice with aberrant numbers of X or Y
chromosomes [25,41]. Thus, by breeding XY* fathers, we obtain
progeny with the following genotypes: XX, XX
Y* (similar to
XXY), XY* (similar to XY), and XY*
X (similar to XO+an extra
pseudoautosomal region, PAR) (see Table S1). After gonadectomy
at day 75, mice with two X chromosomes (XX and XXY) had
higher body weight (p,0.000001) and fat mass (p,0.0005) than
mice with one X chromosome (XY and XO+PAR) (Figure 5A,
5B). The presence of the Y chromosome appeared to have no
effect. We conclude that the inherent genetic difference conferred
by presence of two X chromosomes is responsible for the effects on
body weight and adiposity.
Elevated expression levels of genes escaping X
chromosome inactivation in adipose tissue and liver
A potential mechanism underlying the observed effect of two X
chromosomes on adiposity is the presence of a higher dose of X
chromosome genes in XX compared to XY cells. Although X
inactivation prevents most X genes from being expressed at higher
levels in females, it is well established that a proportion of X
chromosome genes in both mouse and human escape inactivation
[31,32,33,34]. If genes that escape X chromosome inactivation are
expressed at higher levels in metabolic tissues of XX than XY
mice, they may contribute to the differences that we have observed
between XX and XY mice. We evaluated the expression levels in
adipose tissue depots and liver of the FCG mice for protein-coding
genes that have been shown to escape X inactivation in an
interspecific female mouse cell line, or are candidate ‘‘escapees’’
from X-inactivation because of higher expression in XX vs. XO
mice, or XX vs. XY mice (listed in Figure 6A) [34,35,42,43].
We found that 8 of 11 genes in our panel exhibited higher
expression levels in XX compared to XY mouse adipose tissues
(gonadal and/or inguinal) (Figure 6A). These include four genes
that are established X escapees in both mouse and human (Eif2s3x,
Kdm6a, Ddx3x, Kdm5c), and these genes also show higher expression
in gonadectomized XX liver as well as adipose tissue (Figure 6A–
6D). Another gene that is also known to escape inactivation in
mouse and human, Mid1, exhibited a unique expression pattern,
with significantly lower expression in XX compared to XY
inguinal fat and liver. The mechanism for this reduced expression
in XX tissues is unclear, but nevertheless constitutes a difference
that is determined by sex chromosome complement. Only a
handful of genes (Ddx3x, Uba1, Mid1) showed significant differ-
ences in expression levels between gonadal female and male mice,
which may reflect long-lasting effects of gonadal hormones on
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PLoS Genetics | www.plosgenetics.org 7 May 2012 | Volume 8 | Issue 5 | e1002709Figure 4. Diet-induced fatty liver and impaired glucose homeostasis are more pronounced in XX than XY mice. FCG mice were fed a
high fat-high carbohydrate diet for 16 weeks. All values represent mean 6 SEM. (A) XX mice had increased liver mass and hepatic triglyceride levels
compared to XY mice. (B) Hematoxylin and eosin staining of liver sections shows hepatic lipid droplet accumulation in XX mice. In the lower panel,
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PLoS Genetics | www.plosgenetics.org 8 May 2012 | Volume 8 | Issue 5 | e1002709expression levels of these genes. These results reveal that a subset
of genes escaping X inactivation are expressed at elevated levels in
metabolic tissues of XX compared to XY mice. These genes
represent candidates for future studies to identify the mechanism
by which increased X chromosome dosage affects adiposity and
metabolism.
thin layer chromatography demonstrates increased triglyceride levels in liver of XX mice relative to XY mice. (C) Fasting glucose and insulin levels, and
homeostatic model assessment (HOMA) were determined. XX mice had significantly higher insulin levels than XY mice. (D) Fasting plasma triglyceride
(TG) and free fatty acid (FFA) levels were higher in gonadal males than in gonadal females. (E) Increased triglyceride accumulation in XX liver is
associated with increased peroxisome proliferator-activated receptor c (Pparg) and diacylglycerol acyltransferase 1 (Dgat1) mRNA levels. (F) Increased
expression levels for fatty acid oxidation genes acyl CoA oxidase 1 (Aox1) and carnitine palmitoyltransferase 1a (Cpt1a) in liver of XX mice. (G)
Increased expression of Aox1 in skeletal muscle of gonadal male mice. *, p,0.05; **, p,0.01; ***, p,0.001; {,p ,0.0001.
doi:10.1371/journal.pgen.1002709.g004
Figure 5. The number of X chromosomes determines differences in body weight and adiposity. (A) Body weight following gonadectomy
at day 75 of mice having the indicated sex chromosome complements fed a chow diet. The Y* chromosome has been described [41], and the near
equivalent genotype in terms of X and Y chromosome complement is shown. Two groups of mice with two X chromosomes had higher body weight,
relative to mice with one X chromosome, beginning at 8 weeks after GDX and thereafter (p,0.000001). Mice with a Y chromosome did not differ
from mice lacking a Y chromosome. (B) Body weight and body composition determined by NMR in mice shown in panel (A) at 9 months after GDX.
Values shown for all bars represent mean 6 SEM for the number of each genotype indicated. **, p,0.01; ***, p,0.001; {,p ,0.0001; {,p ,0.000001.
doi:10.1371/journal.pgen.1002709.g005
Sex Chromosome Complement Influences Adiposity
PLoS Genetics | www.plosgenetics.org 9 May 2012 | Volume 8 | Issue 5 | e1002709Discussion
Sexual dimorphism occurs in many fundamental metabolic
processes, which likely influence the development of metabolic
diseases. Understanding the sex-specific factors and pathways that
promote or mitigate disease may lead to a better understanding of
disease pathogenesis and useful interventions. The present results
illustrate the complex interplay between several major classes of
sex-specific factors that cause sexual dimorphism in obesity, and
highlight the utility of the FCG model for investigating such
interactions. For the first time, we demonstrate that sex
chromosome complement, independent of gonadal sex, has
substantial effects on body weight and adiposity in adult mice on
a chow diet, and on the rate of weight gain in mice fed a high fat
diet. We found that the increased adiposity observed in XX mice is
attributable to the presence of two X chromosomes rather than to
the lack of a Y chromosome. These results focus attention of future
studies on a specific set of X chromosome genes that exhibit
altered expression in metabolic tissues of XX compared to XY
animals because of escape from X chromosome inactivation or sex
chromosome-specific imprinting.
The role of sex hormones in the determination of body weight
and adiposity has been documented in many studies in humans
and rodent models. For example, gonadally intact male mice have
higher body weight, and exhibit more pronounced diet-induced
weight gain, than females; this sex difference is reversed partially
Figure 6. Differential gene expression in liver and fat tissues of X chromosome genes that escape inactivation. Genes previously
shown to escape X chromosome inactivation (see text) were assessed for expression levels by quantitative PCR in liver and adipose tissue
(subcutaneous inguinal and gonadal depots) of gonadectomized, chow fed FCG mice shown in Figure 1B (10 months post-GDX). (A) Statistical
differences in gene expression levels among the FCG genotypes for genes escaping X chromosome inactivation. For each gene, the p value for
differences between XX and XY, and female (F) vs. male (M), are shown. Several escapees exhibit increased expression in liver and/or adipose tissues
of XX compared to XY mice; a few genes also exhibit differences between levels in gonadal females and gonadal males. Mid1 shows a unique pattern,
with lower expression levels in XX compared to XY tissues. The full name for Rik is 2610029G23Rik. NS, not significantly different. (B–D) mRNA levels
are shown for liver and gonadal fat tissue of FCG mice for Eif2s3x, Kdm6a, and Ddx3x. Values shown for all bars represent mean 6 SEM for the number
of each genotype indicated. **, p,0.01; {,p ,0.000001.
doi:10.1371/journal.pgen.1002709.g006
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loss of estrogens with menopause is associated with deposition of
visceral body fat, and this effect can be ameliorated to some extent
by hormone replacement therapy [45,46,47,48]. Modulating
testosterone levels also affects adipose tissue storage in healthy
young men, with testosterone levels inversely correlated with
adipose tissue mass [49]. Thus, it is clear that gonadal hormones
play a strong role in determining sex differences in adiposity in
mice and humans. However, few models have allowed the
interrogation of potential genetic effects underlying sex differences
independent of gonadal hormones.
In our characterization of the FCG mice, body weight and/or
metabolic traits were influenced by all three of the major classes of
sex-biasing factors: activational (acute) hormonal effects, long-
lasting (organizational) hormonal effects, and sex chromosome
effects [25,28]. Several traits were influenced by interactions
between two or more of these factors. At 75 days of age, gonadal
males weighed 25–28% more than gonadal females, irrespective of
their sex chromosome complement, suggesting that the sex
difference is caused by gonadal secretions. That conclusion was
confirmed because the sex difference disappeared by one month
after gonadectomy. However, further analysis of the FCG model
revealed that attributing sex differences in body weight solely to
gonadal hormones would be a significant oversimplification. Prior
to gonadectomy, XX mice weighed 6–9% more than XY mice, in
both gonadal males and females. The XX vs. XY difference
became dramatically larger after gonadectomy, with XX mice
having up to 2-fold greater adiposity than XY mice. Layered on
top of this was an effect of Sry (likely mediated by long-lasting
effects of the original gonadal hormones), as without their gonads,
gonadal female XX mice lacking Sry had higher body weight, fat
pad mass, and plasma leptin levels than gonadal male XX mice
possessing Sry. The results indicate that although sex chromosome
effects act in both intact and gonadectomized mice, gonadal
hormones blunt the influence of sex chromosome complement,
suggesting that the hormones may have different effects depending
on the chromosomal sex of cells. Thus, understanding how males
and females differ from one another is not simply a matter of
studying an apparently dominant factor that causes the sex
difference, but requires disentangling the interactive effects of
several sex-biasing factors.
The increased body weight of XX mice was preceded by
increased food intake compared to XY mice; interestingly, this was
restricted to the light portion of the diurnal cycle (see Figure 2A).
After differences in adiposity were established between XX and
XY mice, food intake was not distinguishable, but leptin levels
were elevated in XX mice, suggesting relative leptin resistance in
the XX mice. Since there were no detectable compensatory
changes in energy expenditure or physical activity in XX mice,
this increase in food intake likely contributes to the increased body
weight. The increased consumption of carbohydrates during the
light period was reflected in slightly elevated RQ during the same
period. This difference was evident even before the GDX XX
mice had increased body weight. A trend toward increased food
intake during the light period continued after the XX mice were
substantially heavier (at 10 months post-GDX), although it was no
longer statistically significant. A recent study has shown that
mouse food intake during the light period of the circadian cycle
leads to greater weight gain than equivalent intake during the dark
period, when mice typically consume the majority of their calories
[50]. Many other studies have provided evidence that energy
balance is tightly integrated with the circadian clock and that
disruption of this cycle has detrimental effects on many aspects of
metabolism [51,52]. Thus, a focus of future studies in the FCG
model will be the investigation of whether sex chromosome
complement influences regulation of the circadian clock and/or
networks for food consumption and satiety.
Sex chromosome complement had a key effect on the response
to a high fat diet, with XX mice having an almost immediate
divergence in weight gain from XY mice. An interesting finding
was the greater expansion in the subcutaneous fat depot in XX
mice, and greater increase in the gonadal fat depot in XY mice. It
has been shown that women store a greater percentage of dietary
fatty acids in subcutaneous adipose tissue than men [53]. Our
observations in mice raise the possibility that sex chromosome
complement may be a factor in determining the propensity to store
fat in various anatomical depots.
The high fat diet also led to the development of more
pronounced metabolic dysregulation in XX mice, particularly
fatty liver. Non-alcoholic fatty liver disease affects up to one-third
of American adults, usually in association with obesity and insulin
resistance [54,55]. The occurrence of fatty liver disease and its
progression to cirrhosis, end-stage liver disease and hepatocellular
carcinoma are influenced by many factors, including genetic
factors. Our studies reveal that XX sex chromosome complement
is one genetic factor that promotes development of fatty liver in
mice. It is likely that the fatty liver in XX mice fed the high fat diet
was influenced by risk factors such as increased adiposity and
hyperinsulinemia. Interestingly, however, fatty liver did not
parallel circulating triglyceride and fatty acid levels, which were
more influenced by gonadal sex (likely influenced by organiza-
tional effects of gonadal hormones) rather than sex chromosome
complement. In future studies, it will be interesting to determine
whether sex chromosome complement also influences the
propensity for progression of steatotic livers to cirrhosis, the basis
of which is currently not understood.
The sex chromosome effects reported here indicate that
inherent sex differences in expression of X chromosome genes,
stemming from the difference in number or parental imprint of X
genes in XX vs. XY mice, contribute to sex differences in adiposity
and metabolic disease. The sex chromosome effects are unlike
typical linkage of genes to phenotype, because they are not caused
by differences in the genetic sequence of the X chromosome,
which was identical in all mice studied. Because X-inactivation
effectively reduces the inherent bias toward higher expression of X
genes in XX mice relative to XY mice, prime candidates for the
genes causing the adiposity are those that escape X inactivation, or
those that receive a parental imprint, leading to differential
expression in XX compared to XY mice [28].
A significant proportion of X chromosome genes (15–25%) are
thought to escape X chromosome inactivation in humans [56],
and most of the genes escaping X inactivation in mice also escape
in humans [34]. We tested expression levels of candidate genes
that are known to escape inactivation in both mouse and human
(Eif2s3x, Kdm6a, Kdm5c, Ddx3x) or have a Y paralogue with some
evidence for higher expression in XX than XY mice and humans
(Usp9x, Uba1) [31,34,35,42,43,57]. Each of these genes was
expressed at higher levels in XX than XY gonadal fat in
gonadectomized mice, providing evidence that these genes escape
inactivation in a metabolic tissue. Thus, these genes are candidates
for those causing the XX–XY differences in physiology and
adiposity reported here. Alternatively, differential expression of X
chromosomes escapee genes could occur secondarily to differences
in adiposity between XX and XY mice, in which case they may be
downstream players in the observed metabolic differences. In
addition to sex chromosome genes, autosomal genes that are
differentially expressed in response to X chromosome gene dosage
may contribute to the observed metabolic differences between XX
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genes involved in mitochondrial metabolism and protein transla-
tion occurs in tissues of XX compared to XO mice, but the
metabolic consequences are not known [35].
A reasonable question is whether these studies in the mouse
have relevance to obesity in humans. Unusual numbers of sex
chromosomes in human conditions such as Klinefelter (XXY) and
Turner (XO) syndromes are associated with metabolic disease
and/or adiposity [58,59,60,61]. However, in these diseases,
endocrine abnormalities may contribute and are difficult to
distinguish from the sex chromosome effects. The utility of our
model is that it is genetically tractable in a way that human studies
are not. Since fundamental genetic and metabolic processes are
shared between mice and humans, we propose that the
identification of X-linked genes that have a large impact on
obesity in the mouse could lead to the discovery of novel
mechanisms that impact obesity in humans. The increasing
longevity of the human population means that the hypogonadal
period may extend for up to half of a persons’ lifetime, and the
inherent genetic sex differences uncovered here may have
important ramifications. Furthermore, since the gene content of
the X chromosome is conserved in mouse and human, and several
of the same genes escape inactivation in both species, there is hope
that characterizing the action of X gene(s) in mouse will advance
our understanding of human metabolic disease.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
appropriate committee. All experiments in this paper were carried
out with UCLA IACUC approval.
Mice
‘‘Four core genotypes’’ (FCG) mice were used. ‘‘Male’’ denotes
a mouse with testes, and ‘‘female’’ denotes a mouse with ovaries.
In these mice, the testis-determining Sry gene is deleted from the Y
chromosome and inserted as a transgene onto an autosome
[27,36]. Thus, gonadal type is no longer controlled by sex
chromosome complement (XX vs. XY), and the effect of sex
chromosome complement on traits can be studied independent of
the gonadal type of the mouse. For the present study, the FCG
model was transferred to a C57BL/6J (B6) genetic background by
backcrossing male MF1 XY
2Sry (Y
2 chromosome denotes
deletion of Sry; Sry denotes presence of the autosomal Sry
transgene) to B6 XX females for 13–14 generations. Four groups
of mice are generated, XX and XY gonadal males (XXM and
XYM, carrying the Sry transgene), and XX and XY gonadal
females (XXF and XYF, without Sry). In all the FCG mice the Y
2
chromosome derives from strain 129. Advantages and caveats in
the use of FCG mice have been discussed [25,27].
Gonadectomy was performed at 75 days of age. Under
isoflurane anesthesia, mice were given a subcutaneous injection
of carprofen and the gonads were removed. Using aseptic
procedures, gonads were exposed, clamped, ligated, and excised.
Successful gonadectomy was confirmed at the time of euthanasia.
Although no gonadal hormones are present in GDX mice, sex
steroid hormones (e.g., androgens or estrogens produced de novo in
adrenal, adipose tissue, or brain) are probably present in mice after
GDX.
In one study, we compared mice born of XY* fathers, which
have an aberrant Y chromosome that recombines abnormally with
the X chromosome. The XY* males from strain B6Ei.LT-Y*/EiJ
from the Jackson Laboratories were crossed with B6/J females for
2–3 generations, so that the mice were a mixture of C57BL/6J and
C57BL/EiJ strains. In all case littermates were compared, so that
the percentage of the two B6 parental strains was comparable
across groups. We studied four different types of progeny of XY*:
XX, XX
Y*, XY*, and XY*
X. These mice are roughly similar to
XX, XXY, XY, and XO+an extra pseudoautosomal region,
respectively (see Table S1) [41].
Gonadal males and females were housed in separate cages and
maintained at 23uC with a 12:12 light:dark cycle. For studies using
chow fed mice, mice were fed Purina 5001 chow diet (approxi-
mately 5% fat, PMI Nutrition International, St. Louis, MO)
throughout their lifetime. For high fat diet treatment, mice were
gonadectomized at 75 days of age and 4 weeks later were switched
from chow to a high fat diet containing 35% fat, 33%
carbohydrate (Diet F3282, Bio-Serve, Frenchtown, New Jersey).
Fresh diet was added to cages twice per week. Animal studies were
performed under approval of the UCLA Institutional Animal Care
and Use Committee.
Genotyping and karyotyping
DNA was extracted from tails using Chelex resin (Bio-Rad,
Hercules, CA). The genotype of mice was determined by PCR
based on the presence or absence of Sry and of the X/Y
chromosome paralogues Jarid1d/Jarid1c [41]. Ear fibroblasts
from offspring of XY* mice were cultured and metaphase spreads
were used to determine the sex chromosome status based on
karyotype [41].
Measurement of body weight and body composition
FCG and XY* mice were weighed on postnatal days 21, 45 and
day 75 and then gonadectomized (GDX) on day 75. After GDX
mice were weighed at weekly intervals. At various ages, body
composition was determined with a Mouse Minispec apparatus
(Bruker Woodlands, TX) with Echo Medical Systems (Houston,
TX) software. This apparatus uses NMR spectroscopy for fat and
lean mass measurements with coefficients of variation of ,3%
[62]. Correlation between NMR and gravimetric measurements is
better than 0.99.
Energy balance measurements
Eight calibrated Oxymax metabolic cages (Columbus Instru-
ments) were used to detect numerous variables related to energy
balance: food and water intake, horizontal and vertical physical
activity, heat production, oxygen consumption, CO2 production,
energy expenditure, and respiratory quotient (RQ). The room
housing the metabolic cages was kept very quiet to avoid stress or
other interference with the activity of the mice. Mice were housed
individually in the Oxymax metabolic cages from midday Friday
to midday Monday, during which parameters were monitored
dynamically at 20 min intervals. Mice had free access to water and
food resented from a food hopper attached to a scale. Data for 3
full nights and 2 full days were analyzed.
Glucose homeostasis
Baseline glucose and insulin levels were determined after a 4.5-
hour fast (8:00AM–12:30PM). Glucose tolerance tests were
performed after similar fast by injecting mice intraperitoneally
with glucose (2 mg/g body weight) and determining glucose levels
(using Lifescan OneTouch glucose meter) at 15, 30, 60 and
180 minutes after injection [63].
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Liver, quadriceps skeletal muscle, gonadal fat, inguinal fat and
brown fat were dissected out rapidly, flash frozen in liquid
nitrogen, and stored at 280uC. RNA was isolated from tissues
using Trizol (Invitrogen, Carlsbad, CA, USA) and treated with
RNase-free DNase (Promega, Madison, USA) to remove possible
genomic DNA contamination. First-strand cDNA synthesis was
generated by reverse transcription with SuperScript III RNase H-
RT (Invitrogen). Quantitative real time PCR (n=7–8 per
genotype) was performed on an ABI 7300 Sequence Detection
system (Applied Biosystems, Foster City, CA, USA) using the
SensiMixPlusSYBR Green & Fluorescein Master Mix Kit
(Quantace, USA). Two or three control genes were amplified as
normalization controls: beta-2 microglobulin, TATA box-binding
protein (TBP), and BC022960. Primer sequences for all genes
assessed are listed in Table S2. Cycling conditions were: 95uC for
10 min; 40 cycles of 95uC for 15 sec, 60uC for 30 sec and 72uC for
30 sec. assay contained a standard curve for the target gene and
control genes with 4 serial dilution points of control cDNA: 50 ng,
10 ng, 2 ng and 0.4 ng. Dissociation curves were examined to
eliminate the possibility of genomic DNA contamination.
Statistical analyses
Groups were compared using two-way ANOVA (NCSS 2001;
Number Cruncher Statistical Systems, Kaysville, UT, USA) with
main factors of sex (gonadal male vs. gonadal female, same as Sry
present vs. absent) and sex chromosome complement (XX vs. XY).
Sometimes a three-way repeated measures ANOVA was also
applied with between factors of sex and sex chromosome
complement, and within factors of gonadal status (before vs. after
GDX) or age. Statistical analyses (main effects of each of the two
factors, or interaction of the two) are presented if they were
statistically significant, but usually not if they were not significant
(p.0.05). Multiple regression analyses of energy metabolism data
was performed with Stata Data Analysis and Statistical Software
(StataCorp LP, College Station, TX).
Supporting Information
Figure S1 Energy metabolism measurements in FCG mice fed a
chow diet. Oxygen consumption (VO2) and physical activity along
horizontal and vertical axes were determined in mice individually
housed in metabolic cages at 4 weeks (A) and 10 months (B)
following GDX. No significant differences were detected among
the four genotypes in these parameters during dark or light cycles.
(C) Thermogenic gene expression was assessed in brown adipose
tissue at 4 weeks and 10 months following GDX. Uncoupling
protein 1 (Ucp1) gene expression was higher in male than female
mice at 4 weeks after GDX, but this difference was no longer
apparent at 10 months. No significant differences in peroxisome
proliferator-activated receptor c coactivator a (Pgc1) mRNA levels
were detected. Each bar represents mean 6 SEM for the number
of mice of each genotype indicated. **, p,0.01.
(DOC)
Figure S2 Glucose homeostasis and gene expression in FCG
mice fed a chow diet. (A) Glucose and insulin levels were
determined after a 4 hour fast (08:00–12:00). Glucose tolerance
was assessed by intraperitoneal injection of glucose and blood
collection at intervals over 3 hours. The GTT AUC represents the
area under the curve of blood glucose levels plotted from time 0 to
3 hours post glucose injection. (B) Gene expression determined by
qPCR for acyl CoA oxidase 1 (Aox1) and carnitine palmitoyl-
transferase (Cpt) in muscle and liver, as indicated. Each bar
represents mean 6 SEM for the number of mice of each genotype
indicated. *, p,0.05; **, p,0.01; {,p ,0.0001.
(DOC)
Table S1 Sex chromosome composition of offspring from XY* x
XX mice. The copy number of specific regions of the X and Y
chromosomes present in mice of each genotype is indicated. NPX,
non-pseudoautosomal region of the X chromosome. MSY, male-
specific region of the Y chromosome. Xm, maternal X imprint.
Xp, paternal X imprint. Refer to [41] for illustrations of
chromosome structures.
(DOC)
Table S2 Primer sequences for gene expression analyses by
qPCR.
(DOC)
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